Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis

Diabetic cardiomyopathy (DCM) is characterized by cardiac dysfunction and cardiomyocyte apoptosis. Oxidative stress is suggested to be the major contributor to the development of DCM. This study was intended to evaluate the protective effect of low molecular weight fucoidan (LMWF) against cardiac dy...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinfeng Yu, Quanbin Zhang, Wentong Cui, Zheng Zeng, Wenzhe Yang, Chao Zhang, Hongwei Zhao, Weidong Gao, Xiaomin Wang, Dali Luo
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2014/420929
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849306771995230208
author Xinfeng Yu
Quanbin Zhang
Wentong Cui
Zheng Zeng
Wenzhe Yang
Chao Zhang
Hongwei Zhao
Weidong Gao
Xiaomin Wang
Dali Luo
author_facet Xinfeng Yu
Quanbin Zhang
Wentong Cui
Zheng Zeng
Wenzhe Yang
Chao Zhang
Hongwei Zhao
Weidong Gao
Xiaomin Wang
Dali Luo
author_sort Xinfeng Yu
collection DOAJ
description Diabetic cardiomyopathy (DCM) is characterized by cardiac dysfunction and cardiomyocyte apoptosis. Oxidative stress is suggested to be the major contributor to the development of DCM. This study was intended to evaluate the protective effect of low molecular weight fucoidan (LMWF) against cardiac dysfunction in diabetic rats. Type 2 diabetic goto-kakizaki rats were untreated or treated with LMWF (50 and 100 mg/kg/day) for three months. The establishment of DCM model and the effects of LMWF on cardiac function were evaluated by echocardiography and isolated heart perfusion. Ventricle staining with H-E or Sirius Red was performed to investigate the structural changes in myocardium. Functional evaluation demonstrated that LMWF has a beneficial effect on DCM by enhancing myocardial contractility and mitigating cardiac fibrosis. Additionally, LMWF exerted significant inhibitory effects on the reactive oxygen species production and myocyte apoptosis in diabetic hearts. The depressed activity of superoxide dismutase in diabetic heart was also improved by intervention with LMWF. Moreover, LMWF robustly inhibited the enhanced expression of protein kinase C β, an important contributor to oxidative stress, in diabetic heart and high glucose-treated cardiomyocytes. In conclusion, LMWF possesses a protective effect against DCM through ameliorations of PKCβ-mediated oxidative stress and subsequent cardiomyocyte apoptosis in diabetes.
format Article
id doaj-art-23eabae009944f2ebb603505696b4664
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-23eabae009944f2ebb603505696b46642025-08-20T03:54:58ZengWileyJournal of Diabetes Research2314-67452314-67532014-01-01201410.1155/2014/420929420929Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte ApoptosisXinfeng Yu0Quanbin Zhang1Wentong Cui2Zheng Zeng3Wenzhe Yang4Chao Zhang5Hongwei Zhao6Weidong Gao7Xiaomin Wang8Dali Luo9Department of Pharmacology, School of Chemical Biology & Pharmaceutical Sciences, Capital Medical University, Youanmenwai Street, No. 10 Xitoutiao, Fengtai District, Beijing 100069, ChinaInstitute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, ChinaDepartment of Pharmacology, School of Chemical Biology & Pharmaceutical Sciences, Capital Medical University, Youanmenwai Street, No. 10 Xitoutiao, Fengtai District, Beijing 100069, ChinaDepartment of Pharmacology, School of Chemical Biology & Pharmaceutical Sciences, Capital Medical University, Youanmenwai Street, No. 10 Xitoutiao, Fengtai District, Beijing 100069, ChinaDepartment of Pharmacology, School of Chemical Biology & Pharmaceutical Sciences, Capital Medical University, Youanmenwai Street, No. 10 Xitoutiao, Fengtai District, Beijing 100069, ChinaDepartment of Pharmacology, School of Chemical Biology & Pharmaceutical Sciences, Capital Medical University, Youanmenwai Street, No. 10 Xitoutiao, Fengtai District, Beijing 100069, ChinaDepartment of Pharmacology, School of Chemical Biology & Pharmaceutical Sciences, Capital Medical University, Youanmenwai Street, No. 10 Xitoutiao, Fengtai District, Beijing 100069, ChinaDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USADepartment of Physiology, Capital Medical University, Beijing 100069, ChinaDepartment of Pharmacology, School of Chemical Biology & Pharmaceutical Sciences, Capital Medical University, Youanmenwai Street, No. 10 Xitoutiao, Fengtai District, Beijing 100069, ChinaDiabetic cardiomyopathy (DCM) is characterized by cardiac dysfunction and cardiomyocyte apoptosis. Oxidative stress is suggested to be the major contributor to the development of DCM. This study was intended to evaluate the protective effect of low molecular weight fucoidan (LMWF) against cardiac dysfunction in diabetic rats. Type 2 diabetic goto-kakizaki rats were untreated or treated with LMWF (50 and 100 mg/kg/day) for three months. The establishment of DCM model and the effects of LMWF on cardiac function were evaluated by echocardiography and isolated heart perfusion. Ventricle staining with H-E or Sirius Red was performed to investigate the structural changes in myocardium. Functional evaluation demonstrated that LMWF has a beneficial effect on DCM by enhancing myocardial contractility and mitigating cardiac fibrosis. Additionally, LMWF exerted significant inhibitory effects on the reactive oxygen species production and myocyte apoptosis in diabetic hearts. The depressed activity of superoxide dismutase in diabetic heart was also improved by intervention with LMWF. Moreover, LMWF robustly inhibited the enhanced expression of protein kinase C β, an important contributor to oxidative stress, in diabetic heart and high glucose-treated cardiomyocytes. In conclusion, LMWF possesses a protective effect against DCM through ameliorations of PKCβ-mediated oxidative stress and subsequent cardiomyocyte apoptosis in diabetes.http://dx.doi.org/10.1155/2014/420929
spellingShingle Xinfeng Yu
Quanbin Zhang
Wentong Cui
Zheng Zeng
Wenzhe Yang
Chao Zhang
Hongwei Zhao
Weidong Gao
Xiaomin Wang
Dali Luo
Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis
Journal of Diabetes Research
title Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis
title_full Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis
title_fullStr Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis
title_full_unstemmed Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis
title_short Low Molecular Weight Fucoidan Alleviates Cardiac Dysfunction in Diabetic Goto-Kakizaki Rats by Reducing Oxidative Stress and Cardiomyocyte Apoptosis
title_sort low molecular weight fucoidan alleviates cardiac dysfunction in diabetic goto kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis
url http://dx.doi.org/10.1155/2014/420929
work_keys_str_mv AT xinfengyu lowmolecularweightfucoidanalleviatescardiacdysfunctionindiabeticgotokakizakiratsbyreducingoxidativestressandcardiomyocyteapoptosis
AT quanbinzhang lowmolecularweightfucoidanalleviatescardiacdysfunctionindiabeticgotokakizakiratsbyreducingoxidativestressandcardiomyocyteapoptosis
AT wentongcui lowmolecularweightfucoidanalleviatescardiacdysfunctionindiabeticgotokakizakiratsbyreducingoxidativestressandcardiomyocyteapoptosis
AT zhengzeng lowmolecularweightfucoidanalleviatescardiacdysfunctionindiabeticgotokakizakiratsbyreducingoxidativestressandcardiomyocyteapoptosis
AT wenzheyang lowmolecularweightfucoidanalleviatescardiacdysfunctionindiabeticgotokakizakiratsbyreducingoxidativestressandcardiomyocyteapoptosis
AT chaozhang lowmolecularweightfucoidanalleviatescardiacdysfunctionindiabeticgotokakizakiratsbyreducingoxidativestressandcardiomyocyteapoptosis
AT hongweizhao lowmolecularweightfucoidanalleviatescardiacdysfunctionindiabeticgotokakizakiratsbyreducingoxidativestressandcardiomyocyteapoptosis
AT weidonggao lowmolecularweightfucoidanalleviatescardiacdysfunctionindiabeticgotokakizakiratsbyreducingoxidativestressandcardiomyocyteapoptosis
AT xiaominwang lowmolecularweightfucoidanalleviatescardiacdysfunctionindiabeticgotokakizakiratsbyreducingoxidativestressandcardiomyocyteapoptosis
AT daliluo lowmolecularweightfucoidanalleviatescardiacdysfunctionindiabeticgotokakizakiratsbyreducingoxidativestressandcardiomyocyteapoptosis